63459-404 NDC - TIAGABINE HYDROCHLORIDE

Drug Information

  • Product NDC: 63459-404
  • Proprietary Name:
  • Non Proprietary Name: Tiagabine Hydrochloride
  • Active Ingredient(s): 4 mg/1 TIAGABINE HYDROCHLORIDE
  • Administration Route(s):
  • Dosage Form(s): TABLET, FILM COATED

Labeler Information

Field Name Field Value
Labeler Name: Cephalon, LLC
Product Type: DRUG FOR FURTHER PROCESSING
FDA Application Number:
Marketing Category: DRUG FOR FURTHER PROCESSING
Start Marketing Date:2/8/2010
End Marketing Date:4/30/2024

Package Information

No. Package Code Package Description Billing Unit
163459-404-01100 TABLET, FILM COATED in 1 BOTTLE (63459-404-01)EA
263459-404-3030 TABLET, FILM COATED in 1 BOTTLE (63459-404-30)EA
363459-404-99122881 TABLET, FILM COATED in 1 DRUM (63459-404-99)

NDC Record

Field Name Field Value Definition
PRODUCT NDC63459-404The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
START MARKETING DATE4/1/2001This is the date that the labeler indicates was the start of its marketing of the drug product.
MARKETING CATEGORY NAMENDAProduct types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
LABELER NAMECephalon, LLCName of Company corresponding to the labeler code segment of the Product NDC.
PRODUCT NDC63459-404The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
START MARKETING DATE2/8/2010This is the date that the labeler indicates was the start of its marketing of the drug product.
MARKETING CATEGORY NAMEDRUG FOR FURTHER PROCESSINGProduct types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
LABELER NAMECephalon, LLCName of Company corresponding to the labeler code segment of the Product NDC.

Download Record

Download this NDC record record in Text format: Export

Download this NDC record record in Excel (CSV) format: Export

Download this NDC record record in XML format: Export

This page was last updated on: 6/6/2025

Previous Code
Next Code